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ABSTRACT

The pre-analytical phase contributes 60-70% of total error of the total testing
process (TTP) (Plebani 2006). The pre-analytical phase can be further divided
into two phases; the ‘pre-preanalytical’ and ‘preanalytical’ phases, which
commonly includes tasks performed outside of the laboratory walls, and tasks
perform within the laboratory’s walls and control, respectively. Additionally,
medical care reimbursement policies in the U.S. along with the need to efficiently
produce quality results and reduce the costs to clients, has caused the
microbiology lab to move from on-site to more resourcefully abundant
consolidate labs (Sautter 2014). Serving many satellite facilities, it is of interest
to look at the pre-preanalytical phase to ensure specimen accountability when
transported over the distance to the core laboratory.

While automation has assisted in reducing errors in all phases of testing,
automation in the pre-analytical microbiology laboratory has been slower due to
its inherent variation (Mulatero 2011). In addition, the lack of well-defined quality
indicators in the pre-preanalytical phase makes it more difficult to monitor
possible errors. Plebani encourages the best way to reduce errors in the prepreanalytical phase is to work interdepartmentally and monitor compliance to
standard operating procedures (SOP).

vii

This study utilizes Plebani’s approach to encourage specimen accountability
between sending facilities and the core microbiology laboratory. Focusing on the
transportation element in the pre-preanalytical phase, common non-compliance
issues were identified and used as pre-defined quality indicators to communicate
as standardized emails to non-compliant departments over of a course of five
months in 2017. By reaching a consensus on adjustment of workflow and duties,
quality monitoring data of non-compliance issues had been compiled and
communicated to enhance specimen accountability at a consolidated core
microbiology lab without the need of automation in the pre-preanalytical phase.
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INTRODUCTION

The paradigm of the laboratory testing process has been described as ‘brain-tobrain loop’ that encompasses the total testing phase (TTP) by Lundberg decades
ago in 1981. The nine steps of TTP are ordering, collection, identification,
transportation, preparation, analysis, reporting, interpretation, and action;
essentially beginning and ending in the mind of physician in order to treat a
patient (Lungberg 1981). These steps have been classified into three phases:
pre-analytical, analytical, and post-analytical phases. Quality improvement has
primarily been focused at the analytical phase, since the wrong result can
adversely affect patient outcome. With the contribution of standardized
techniques, reagents, automated instrumentation, information technology, and
methods in quality control and assurance; error rates in the analytical phase have
seen a ten-fold reduction (Plebani 2012).

The main contributor of error rates in the TTP stem from the pre-analytical phase
with a low prevalence of them actually leading to adverse patient outcomes
(Hawkins 2012). Such errors can delay result turnaround time and patient
treatment for routine diagnostics. Decrease in customer satisfaction due to the
need of recollection may affect the perception of quality for the laboratory.

The pre-analytical phase can be further divided into two categories; ‘prepreanalytical’ and ‘preanalytical’ (Plebani 2006). ‘Pre-analytical’ activities inside

the laboratory such as sorting and routing, pour-off aliquoting, pipetting and
mislabeling, and improper centrifugation of specimens account for 3%-5% of the
total pre-analytical errors (Hawkins 2012). The ‘pre-preanalytical’ tasks
performed by personnel outside of the laboratory contribute the most error in
laboratory’s TTP quality. Contributing 46%-68% of errors, the ‘pre-preanalytical’
category includes “inappropriate test request, order entry, patient/specimen
misidentification, sample collection from infusion route, sample collection
(hemolysis, clotting, insufficient volume, etc.) inappropriate container, handling,
storage, and transportation” (Hawkins 2012). Well defined quality indicators (QI)
in the analytical phase monitor laboratory test performance and efficiency,
however definitions for QI in the pre-analytical phase are not fully established.
(Plebani 2012). A definition issued by the International Organization for
Standardization in 2008 states that errors need to be evaluated in all phases of
TTP, in or out of the laboratory, and centered about patient care. Table 1 lists
sixteen quality indicators developed by the IFCC Working Group for the preanalytical phase based on globally collected data (Sciacovelli 2009). These
indices do not assess possible patient effects and translate into improvement in
the laboratory; the best approach for pre-analytical error reduction is to monitor
adherence to procedures (SOP) and compliance that may vary from institution to
institution (Plebani 2012).
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Table 1. Quality indicators in the pre-analytic phase developed by IFCC Working
Group
QI-1: Appropriateness of test
request

Number of requests with clinical question (%)

QI-2: Appropriateness of test
request

Number of appropriate tests with respect to the clinical
question (%)

QI-3: Examination requisition

Number of requests without physician’s identification
(%)

QI-4: examination requisition

Number of unintelligible requests (%)

QI-5: Identification

Number of requests with erroneous patient
identification (%)

QI-6: Identification

Number of requests with erroneous identification of
physician (%)

QI-7: Test request

Number of requests with errors concerning test input
(%)

QI-8: Samples

Number of samples lost/not received (%)

QI-9: Samples

Number of samples collected in inappropriate
containers (%)

QI-10: Samples

Number of samples haemolysed (haematology,
chemistry) (%)

QI-11: Samples

Number of samples clotted (haematology, chemistry)
(%)

QI-12: Samples

Number of samples with insufficient volumes (%)

QI-13: Samples

Number of samples with inadequate sampleanticoagulant ratio (%)

QI-14: Samples

Number of samples damaged in transport (%)

QI-15: Samples

Number of improperly labelled samples (%)

QI-16: Samples

Number of improperly stored samples (%)

In 2006, Plebani conducted a study using a methodology from 1996 to examine
pre-analytical error rates concluding that the percentage of error had been left
unchanged at approximately 60-70%. What did change was the source of the
3

error type within the pre-analytical phase. Errors involving incorrect collection
tube types and requirements declined when staff committed to compliance of
standard operating procedures (SOP). Meanwhile, an increase of errors was
observed in patient identification despite the introduction of new information
systems. Plebani attributes this shift of unsatisfactory compliance to widelydistributed new written procedures; concluding the need to focus on close
interdepartmental cooperation and compliance (2007).

Microbiology laboratory consolidation into core laboratories have been more
frequent in the U.S. due to funding and medical care reimbursement, and the
need to increase efficiency (Sautter 2015). Core microbiology laboratories
provide the space required for resources to perform microbiological tests in a
central location to serve their affiliate facilities and hospitals in the region.
Examples of these are the TPMG Regional laboratory in Berkeley, California that
serves Kaiser Permanente hospitals and facilities, and Sutter Shared Laboratory
in Livermore, California that serves it’s Sutter customers around the region. Due
to the changing landscape of policies concerning healthcare, other areas in preanalytical phase require attention as well. Specimens travel long distances
before undergoing testing, therefore transportation is an element of the prepreanalytical phase that also must be focused on (Plebani 2012).Transport of
specimens can impact the perception of the laboratory when specimens are not
accounted for and are unable to be tracked. In addition, the final steps in the prepreanalytical phase involve many hands-on sorting or routing, prior to allowing
4

automation to take over the next steps in the overall preanalytical phase of
testing.

Error decline has been observed the analytic phase due to standardization and
improved quality controls and assurance methods; post-analytical errors have
decreased as well thanks to technological advancements in information handling
with laboratory information systems (LIS) linked instruments; even true preanalytical tasks of aliquoting, sorting, and processing have seen improvement in
error rates impart by utilization of automation of robotic workstations (Plebani
2012, Da Rin 2009). In addition, personnel undertaking roles in the analytical
phase are commonly licensed professionals with a good understanding
compliance with SOP. All of the aforementioned have one thing in common being
that they are under the laboratory’s control. The pre-preanalytical phase is out of
the laboratory’s control and errors can be reduce with the when using the right
technological information tools alongside with active involvement and
cooperation of human interactions to monitor compliance (Carraro et al 2012). In
the present study, the focus is specimen accountability in a large microbiology
core laboratory. Without the ability to use automation in the pre-preanalytical
phase, interdepartmental coordination, compliance monitoring, and
communication will be the method to compile data to identify quality indicators in
large microbiology core laboratory. This data may be valuable for identifying
problematic areas that may need further attention to ultimately reduce
preanalytical errors.
5

CORE LABORATORY STUDY

In this present study, the consolidated microbiology laboratory is simply identified
as core lab. The multiple facilities that the core lab services are identified as
sending facilities. The present study was performed between July through
December 2017; data was collected at the end of the study.

Interest in specimen accountability was sparked by an issue that was escalated
to the quality department; requiring investigation and immediate resolution to
prevent recurrence. The issue the core lab encountered involved a specimen on
the core lab’s pending list for multiple days. The core lab’s’ LIS container tracking
feature indicated that the specimen was in the lab and should have been
completed.

The lab assistant that supposedly logged in the specimen was held accountable
for the specimen not reaching the test bench. The common practice for a sending
facility to send a batch of specimens to the core lab is to build a Specimen
Transfer List (STL), serving as packing list to account for specimens included in
the biohazard bags. Creation of a STL automatically changes the status of those
specimens from ‘collected’ to ‘in-transit’ status in the LIS. A third-party courier
service is utilized to deliver shipments from multiple sending facilities to the core
lab. Upon delivery lab personnel sort the biohazard bags, with specimens and
6

STL contained within them, manually into their respective bins according to type
of test. Next, the assigned lab assistant for that test bench may gather their
specimens and proceed to log in the specimens by list number. Logging in by list
number generated by the LIS will log in all specimens on the STL. Status of the
specimens is automatically updated to reflect that it has been received at the
core lab and the test is pending. This is the point of fallacy in the process.
Logging in by list number does not guarantee that specimens on the STL are
truly the specimens in the bag, causing the lab assistant to be liable for the
specimen.

The missing specimen sparked concerns about who should be accountable for
specimens when the sending specimen SOP is not complied with. Sending
facilities are to comply with SOP to build an STL when sending specimens to the
core lab. Instances have been observed when specimens are received at the
core lab in ‘dispatched’ or ‘collected’ status, clearly without a STL. Types of
status updates in the LIS are ‘dispatched’, ‘collected’, ‘in-transit’, ‘pending’, and
'completed'; in that order. Each status serves as means to determine tests
pending from day to day at each step of the testing process, from ordering to
completion of results. ‘Dispatched’ status notifies healthcare personnel of
pending collection, ‘collected’ status informs the local lab that the specimen
should be arriving to the lab, and ‘in-transit’ indicates to the core lab that a
specimen should be arriving within a certain time window. If a specimen is ‘intransit’ exceeding 48 hours, a “no specimen received” (NSR) email is sent to the
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sending facility. The specimen may be lost, not picked up, pending further
instruction, and may require a recollect or recall of the patient. Non-compliance
practices have led to time wasted searching for specimens that have already
reached its destination.

Prior to this study frequency of STL non-compliance practice was uncertain.
Specimens received without a STL at the core lab would be logged in and
undergo processing. The concerning issue arises when specimens are truly lost
and LIS tracking information indicates otherwise. Blame can be placed on either
sending facility or core lab. Failure to comply with SOP leaves little evidence to
where the specimen truly is. The purposes of complying with SOP and produce
STL are to assist sending facilities to reconcile their pending lists, as well alert
the core lab of possible transportation errors; it is the method to track specimens
inter-departmentally.

At the consolidate microbiology core laboratory where this study was performed,
specimens are received from 70 hospitals and facilities. Specimen accountability
is critical when dealing with high volume clinical core laboratories. Automation
and enhanced information management can help reduce errors, but currently
automation integration is slow due in part to the inherent variability involved in
microbiology laboratories (Plebani 2006, Mulatero 2011). Automation of
specimen receiving was out of the scope. Immediate changes had to be
implemented to prevent issues of missing specimens and monitor non-compliant
8

practices. The aim of the this study is to 1) develop and implement a nonautomation solution to prevent missing specimens and, and 2) capture frequency
in which non-compliant practices occur from sending facilities that can help assist
with future solutions in a phase of TTP that already lacks well-define quality
indicators.

MATERIALS & METHODS

The change proposed was implemented over a five month period and reflects
issues encountered only during the night shift at the core lab.

To increase accountability and provide quicker communication of problematic
specimens, a managerial approach was utilized to modify current preanalytical
work processes and duties to aid in identifying non-compliance QI. Current work
processes prior to this study is depicted in Figure 1 with the ‘pre-preanalytical’
processes colored in orange spanning three areas: the sending facility, the
courier, and the core lab. The in-lab ‘preanalytical’ phase of specimen processing
for testing is boxed in green.
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Figure 1. Process map prior to study depicting current processes of sending
specimens to the core lab.

Mitigating issues and capturing data for non-compliance from sending facilities
required the addition of supplemental tasks. The major processes added were: 1)
manually checking all specimens against their respective STL, 2) triaging
specimens received in biohazard bags without STL, or vice versa, and 3)
identifying STL that had multiple tests types ordered considered as ‘mixed STL’.
The addition of the processes can be seen in Figure 2 which includes a method
process to capture non-compliance events within the work shift to communicate
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promptly any discrepancies; thereby improving accountability and releasing
liability of missing specimens at the core lab.

Figure 2. Process map after adjustments made to capture non-compliance
practices when specimens are received at the core laboratory.

Additional tasks required adjustment of existing work duties to ensure lab
assistants were not overworked, maintaining the health and the ability to
complete daily duties of the laboratory as a whole. Implementing change for
sample handling that has many manual processing steps involved mapping out
the process, measuring performance or compliance, showing results, simulation,
simplifying and redesigning, and gaining consensus (Da Rin 2009). Lab
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assistants played a vital role in adjusting tasks since they are familiar with the
intensity and workload of assigned duties. Task adjustments were made in July
and August 2017 and tested. Follow up meetings for input was conducted for two
months until reaching a consensus what on new tasks each position were
responsible for.

Per procedure, sending facilities are to create a STL before sending out
specimens, accurately pack specimens with corresponding patients on the STL,
pack STL within the biohazard bags, and consistently make STL for only one test
type. Mixed tests STL require additional handling at the core lab which increase
the possibility of losing specimens. Any of these 4 issues encountered were
placed in a problem bin that was centrally located near where the lab assistants
performed manual sorting of specimens. The CLS/MLT who was in charge of
sending emails to sending facilities monitored the problem bin and sent
communication to the sending facilities, accordingly.

Utilizing standardized email templates to communicate with sending facilities
provided a means of monitoring non-compliance. Table 2 was the rubric
developed to monitor these non-compliance issues and serve as quality
indicators (QI) for the study. Collection of such data was useful for identifying the
most problematic areas that required attention. The four situation types were
chosen to be the most valuable scenarios to monitor concerning specimen
accountability issues encountered at the core lab and non-compliance of the
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sending facilities; providing possible solutions in the pre-preanalytical phase
which lack well-defined quality indicators.

Table 2. Rubric for Standardize Email of Non-compliance and definition of quality
indicators
Email Template Type

Description

Implications

NSR

Contents in bag missing 1 or
more specimens omit from
STL

True error; missing
specimen identified within
shift hours; effect on
patient care

Delayed specimen found on
nightly pending list1

Possible shared
specimen, not collected,
incorrect order, not picked
up by courier, misrouted

Collected/Dispatched
Status

No STL made; Specimen
shipped without accountability
from local laboratory

Non-compliance w/o
immediate effects on
patient care

STL/Specimen Separate or
Mismatched STL

Possible no STL made;no
accountability from local
laboratory

Non-compliance w/o
immediate effects on
patient care

Mixed Test STL

Increases handling and
sorting when received at
Regional Laboratory;
inefficiency and increase
chance of losing specimen

Non-compliance w/o
immediate effects on
patient care
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hours after collection time, or 8 hours after collection time for Group A Strep

and influenza tests

This method of surveillance and communication was applied to gather data on
the complexity of the preanalytical phase and its initial steps prior to testing, and
the importance of adhering to SOPs (Carraro 2012).
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Data collected based on the pre-defined QI was retrieved at the end of the fifth
month, December 2017. Volume of the four types of e-mails were tallied from the
sent-box of the e-mail client. Any response back from the sending facility
regarding the issue was noted.

RESULTS

Over the course of five months between July 2017 to December 2017, data was
collected by using standardized emails. Standardized emails allowed for ease of
grouping and quantifying the quality indicators as types of non-compliance
monitored. Four types of non-compliance was monitored, 1) No specimen
received (NSR) emails, 2) STL/Specimens separate from specimens, 3) Mixed
STL, and 4) Collected/Dispatched status.

Over the 5 months, 687 emails were communicated to sending facilities. Table 3
below summarizes emails sent monthly based on the quality indicator
categorizations for non-compliance monitoring.
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Table 3. Total number of non-compliance emails sent between July to December
2017.
Month

NSR1

Separated2

Mixed3

No STL4

July

53

4

7

3

August

62

27

20

44

September

61

20

18

35

October

64

24

7

37

November

43

10

11

32

December

62

5

11

27

Totals

345

90

74

178

1) No specimen received (NSR) emails, 2) STL/Specimens separate from
specimens, 3) Mixed STL, and 4) Collected/Dispatched status, No STL made

The NSR-type of non-compliance had the highest occurrence with 345 emails
sent over the course of the study. Of the four types of non-compliance quality
indicators, NSR issues and specimens sent without a STL produced were
observed to be 50% and 26%, respectively. Figure 3 visually represents the
highest frequency of non-compliance issues to least frequent issues. Specimens
not received to the core lab in a timely manner occurred more frequently and was
further investigated.
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Figure 3. Pareto chart of frequency of types of non-compliance emails sent from
July to December 2017. NSR = 50%, Collected = 26%, STL/Specimens Separate
= 13%, Mixed STL = 11%.

Of the 345 NSR emails communicated to the sending facilities only 64 facilities
responded back with explanation of the specimen accountability. The specimens
not received were considered as 1) truly missing and identified as near-miss
thereby relieved the core lab as accountable, 2) the core lab’s mistake of
prematurely sending an NSR email when a specimen was later found in the core
lab and was not logged in, or 3) an issue relating to courier services or other ‘prepreanalytical’ errors outside of the core lab such as requests to cancel, collection
error, missed courier pick up, or misrouted. Figure 4 indicates the core lab was
16

accountable for more specimens missing in the early stages of the newly
implemented work-flow; the following months the core lab had become more
accountable for specimens reducing the number of email feedback for specimens
that was sent an non-compliance e-mail. Truly missing specimens were identified
in 10 incidences in a timely manner during the study and were considered as
near-miss events that prevented delayed turnaround times. Accountability issues
regarding the sending lab or courier appeared to remain constant without
significant improvement. In the month of December there was a spike in emails
sent that was attributed to a suspiciously high number missing specimens from
one sending facility. This outier led to discovery of an entire shipment missed by
the courier. Although timely communication allowed for quick action to locate the
specimens, the specimens were delayed and still was categorized as an
accountability issue regarding the sending facilities and courier.
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Figure 4. 19% response rate of total NSR emails sent indicating outcome for
cause of specimens not received to the core lab.

A total of 345 NSR emails were sent to sending facilities; 64 responses were
tracked. With a low response rate of 19%, the frequency of causes of not
receiving specimens due that were 1) Sending Lab or courier related, 2) Core
Lab accountable and, 3) truly missing specimen, or near-miss with prompt
communication were presented in a pareto chart. Figure 5 indicates issues
originating from the processes of the sending lab and/or courier comprises 67%
of total specimens not received to the core lab.
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Figure 5. Pareto chart of frequency of causes for NSR email to be sent from July
to December 2017.

DISCUSSION

The value of the present five month study, by closely adhering to the changes of
communicating non-compliance issues upon each encounter and monitoring
workflow, is the ability to evaluate errors and survey non-conforming activities in
the ‘pre-preanalytical’ clinical workflow (Carraro 2012). The complexity of
preanalytical errors can be owed in part to the lack of well-define quality
indicators. Pre-defining a laboratory’s own quality indicators in the preanalytical
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phase should be established based on an institutions workflow to increase
specimen accountability.

As seen in the Figure 4, the initial implementation of the process changes by
adding the manual task of scrutinizing each specimen to its STL did not result in
immediate changes in the first two months of July and August. This can be
possibly due to workflow changes and the understanding of new SOP steps. With
the lack of automation and interdepartmental coordination, poor compliance of
written procedures and increase in errors can be observed from overworked staff
(Carraro 2007). Adjusting work duties and processes was effective with a
consensus of the frontline workers in the lab. In the later months, the core lab’s
specimen accountability increase as seen by the decrease of in outcome
responses that indicated less claims of specimens not received when in fact they
were in the core lab’s possession. This decrease confirms that the changes
implemented at the core lab increased accountability. Meanwhile, the outcomes
of missing or late specimens that showed no significant improvement can be
traced back to non-compliance or inadequate processes that are sending lab or
courier related.

While monitoring quality indicators in the pre-analytical phase does not
necessarily translate into quality improvement, it can help identify problematic
processes and promote the need for appropriate preparation, understanding, and
monitoring of SOP compliance (Plebani 2012). This present study highlighted
20

issues that needed to be addressed without the assistance of automation.
Monitoring compliance and adjusting work process were beneficial for specimen
accountability in the core lab as the study progressed. Future considerations to
decrease errors in the TTP should include a team to work with outside sending
facilities and healthcare personnel. This study primarily used standardized email
templates as a means to communicate and quantitate QI. A response rate of
19% regarding non-compliance issues is too low to indicate any definite probable
causes or effects in concerns with the high volume of NSR emails sent out.
Figure 5 indicates that sending facilities compliance and courier related causes of
no specimens received to the core lab would be an ideal initial area to focus on in
the future. With a dedicated outreach team or group to stress the importance of
SOP adherence and a significant increase of response communication to issues
may in turn promote decrease in error rates.

Similar to Carraro’s findings in 2012, when the core lab closely monitored noncompliance and communicated with outside facilities, it was possible to observe
the complexity of the pre-pre-analytical errors and error mitigation due to the
performance of external facilities that are out of the laboratories control. In
addition, a consensus process should be used to develop procedures from both
sending and receiving facilities to further understand the implications of deviating
from procedures, and provide a commitment to adhere to those standard
operating procedures to further increase the accountability of specimens (Carraro
2012).
21
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